Recombinant Human PTGIS Protein，His

PTGIS (prostaglandin I synthase) is an important enzyme involved in the biosynthesis of prostaglandin I2 (prostacyclin), a potent vasodilator and inhibitor of platelet aggregation. Research on PTGIS has gained attention due to its significant role in cardiovascular health and disease, particularly in conditions such as hypertension, atherosclerosis, and thrombosis. The enzyme is primarily expressed in endothelial cells and is essential for maintaining vascular homeostasis. Given the therapeutic potential of targeted prostacyclin pathways, scientists have focused on characterizing PTGIS at a molecular level, studying its structure, function, and regulatory mechanisms. The production of recombinant PTGIS proteins has enabled researchers to investigate enzyme kinetics, interactions with other proteins, and the effects of post-translational modifications. Furthermore, structural studies using techniques like X-ray crystallography and NMR spectroscopy have provided insights into the enzyme's active site and substrate specificity. Understanding PTGIS's function and regulation at a detailed level may offer new avenues for developing pharmacological agents that harness its protective effects against cardiovascular diseases. As a result, PTGIS is not only a critical focus of basic science research but also holds promise for the development of novel therapeutic strategies aimed at improving vascular health.